FDA DEVICE FACTS
HG PRO XP Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs
Healthy Glove Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A powder free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. In addition, these gloves were tested for use with the following chemotherapy drugs at specific concentrations as per ASTM D6978 05 Standard Practice for Assessment of Medical Gloves to P ermeation by Chemotherapy Drugs The gloves have been tested with the following drugs and the respective breakthr ough detection times are listed below. No. Chemotherapy Drugs Concentration Breakthrough detection time in Minutes 1. Blenoxane 15 mg/ml >240 min 2. Busulfan 6 mg/ml >240 min 3. Carboplatin 10 mg/ml >240 min 4. Carmustine (BCNU) 3.3 mg/ml 30.4 min 5. Cisplatin 1.0 mg/ml >240 min 6. Cyclophosphamid e (Cytoxan) mg/ml >240 min 7. Cytarabine mg/ml >240 min 8. Dacarbazine (DTIC) 10.0 mg/ml >240 min 9. Daunorubicin mg/ml >240 min 10. Docetaxel 10.0 mg/ml >240 min 11. Doxorubicin Hydrochloride 2.0 mg/ml >240 min 12. Ellence 2 mg/ml >240 min 13. Etoposide T oposar) 20.0 mg/ml >240 min 14. Fludarabine 25 mg/ml >240 min 15. Fluorouracil 50.0 mg/ml >240 min 16. Ganciclovir 10 mg/ml >240 min 17. Gemcitabine (Gemzar) 38 mg/ml >240 min 18. Idarubicin mg/ml >240 min No. Chemotherapy Drugs Concentration Breakthrough dete ction time in Minutes 19. Ifosfamide 50.0 mg/ml >240 min 20. Irinotecan 20.0 mg/ml >240 min 21. Mechlorethamine HCl 1.0 mg/ml >240 min 22. Melphalan 5 mg/ml >240 min 23. Methotrexate mg/ml >240 min 24. Mitoxantrone 2.0mg/ml >240 min 25. Mitomycin C 0.5 mg/ml >240 min 26. Oxaliplatin 5 mg/ml >240 min 27. Paclitaxel T axol) 6.0 mg/ml >240 min 28. Rituximab 10 mg/ml >240 min 29. Thiotepa 10.0 mg/ml >240 min 30. Triseno x 0.1 mg/ml >240 min 31. V incristine Sulfate 1.0 mg/ml >240 min 32. Vinorelbine 10 mg/ml >240 min Please note that t he following drug ha s extremely low permeation time Carmustine (BCNU) (3.3 mg/ml) at 30.4 minutes
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。